The company’s principal stockholder, Taiwan’s Lin BioScience, agreed to buy around $15M of the offering. The stock rocketed following the IPO on Friday, reaching a session high of $17.50 …
( read original story …)
The Taiwan NEWS
The company’s principal stockholder, Taiwan’s Lin BioScience, agreed to buy around $15M of the offering. The stock rocketed following the IPO on Friday, reaching a session high of $17.50 …
( read original story …)